In vitro release kinetics of biologically active transforming growth factor-β1 from a novel porous glass carrier

Biomaterials

Volumn 18, Issue 12, 1997, Pages 853-859

  Nicoll, Steven B ^a,b   Radin, Shulamith ^a   Santos, Eric M ^a   Tuan, Rocky S ^b   Ducheyne, Paul ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bioactive glass; Bone graft; Sol gel; TGF 1

Indexed keywords

BIOASSAY; BONE; DRYING; GELATION; GLASS; GRAFTS; POROUS MATERIALS; SOL-GELS; SOLS; SOLUTIONS; SYNTHESIS (CHEMICAL);

BIOACTIVE GLASS; TRANSFORMING GROWTH FACTOR; XEROGELS;

HORMONES;

GLASS; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BONE GRAFT; BONE TISSUE; CONTROLLED STUDY; PRIORITY JOURNAL; SUSTAINED DRUG RELEASE; TEMPERATURE;

BIOCOMPATIBLE MATERIALS; BONE SUBSTITUTES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; GELS; GLASS; HUMANS; MATERIALS TESTING; OSTEOGENESIS; PILOT PROJECTS; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0031172688     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(97)00008-2     Document Type: Article

References (53)

1. 1. Cheifetz, S., Weatherbee, J.A., Tsang, M.L.-S. et al. Transforming growth factor system, a complex pattern of cross-reactive ligands and receptors. Cell, 1987, 48, 409-415.
2. 2. Moses, H.L., Yang, E.Y. and Pietenpol, J.A., TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell, 1990, 63, 245-247.
3. 3. Hayashi, I. and Carr, B.I., DNA synthesis in rat hepatocytes: inhibition by a platelet factor and stimulation by an endogenous factor. J. Cell Physiol., 1985, 125, 82-90.
4. 4. Frater-Schroder, M., Muller, G., Birchmeier, W. and Bohlan, P., Transforming growth factor-β inhibits endothelial cell proliferation. Biochem. Biophys. Res. Commun., 1986, 137, 295-302.
5. 5. Kerhl, J.H., Wakefield, L.M., Roberts, A.B. et al., Production of transforming growth factor beta by T lymphocytes and its potential role in the regulation of T cell growth. J. Exp. Med., 1986, 163, 1037-1050.
6. 6. Kerhl, J.H., Roberts, A.B., Wakefield, L.M., Jakowlew, S.B., Sporn, M.B. and Fauci, A.S., Transforming growth factor beta is an important immunomodulatory protein for human B lymphocytes. J. Immunol., 1986, 137, 3855-3860.
7. 7. Shipley, G.D., Pittelkow, M.R., Willie, J.J., Scott, R.C. and Moses, H.L., Reversible inhibition of normal prokeratinocyte proliferation by type beta transforming growth factor growth inhibitor in serum-free medium. Cancer Res., 1986, 46, 2068-2071.
8. 8. Masui, T., Wakefield, L.M., Lechner, J.F., LaVeck, M.A., Sporn, M.B. and Harris, C.C., Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc. Natl. Acad. Sci. USA, 1986, 83, 2438-2442.
9. 9. Jennings, J.C., Mohan, S., Linkart, T.A., Widstrom, R. and Baylink, D.J., Comparison of the biological activities of TGF beta-1 and TGF beta-2: differential activity in endothelial cells. J. Cell Physiol., 1988, 137, 167-172.
10. 10. Wahl, S.M., Hunt, L.M., Wakefield, L.M. et al., Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA, 1987, 84, 5788-5792.
11. 11. Postlethwaite, A.E., Keski-Oja, J., Moses, H.L. and Kang, A.H., Stimulation of chemotactic migration in human fibroblasts by transforming growth factor beta. J. Exp. Med., 1987, 165, 215-256.
12. 12. Sporn, M.B. and Roberts, A.P., Peptide growth factors are multifunctional. Nature, 1988, 332, 304-318.
13. 13. Massague, J., The transforming growth factor beta family. Annu. Rev. Cell Biol., 1990, 6, 597-641.
14. 14. Sandberg, M.M., Aro, H.T. and Vuorio, E.I., Gene expression during bone repair. Clin. Orthop. Rel. Res., 1993, 289, 292-312.
15. 15. Sato, T. and Tuan, R.S., Effect of systemic calcium deficiency on the expression of transforming growth factor-β in chick embryonic calvaria. Dev. Dynam., 1992, 193, 300-313.
16. 3 stimulation of TGF-β expression in chick embryonic calvarial bone. Differentiation, 1993, 52, 139-150.
17. 17. Carrington, J.L., Roberts, A.B., Flanders, K.C., Roche, N.S. and Reddi, A.H., Accumulation, localization, and compartmentalization of transforming growth factor β during endochondral bone development. J. Cell Biol., 1988, 107, 1969-1975.
18. 18. Assoian, R.K. and Sporn, M.B., Type beta transforming growth factor in human platelets: release during platelet degranulation and action on smooth muscle cells. J. Cell Biol., 1986, 102, 1217-1223.
19. 19. Oklund, S.A., Prolo, D.J., Gutierrez, R.V. and King, S.E., Quantitative comparisons of healing in cranial fresh autografts, frozen autografts and processed autografts, and allografts in canine skull defects. Clin. Orthop. Rel. Res., 1978, 205, 269-291.
20. 20. Parrish, F.F., Homograft of bone. Clin. Orthop. Rel. Res., 1972, 87, 36-42.
21. 21. Carnesale, P.L. and Sporn, J.D., A clinical comparative study of autogenous and homogeneous grafts. J. Bone Joint Surg., 1961, 41A, 887-894.
22. 22. Damien, C.J. and Parsons, J.R., Bone graft and bone graft substitutes: a review of current technology and applications. J. Appl. Biomater., 1991, 2, 187-208.
23. 23. Gombotz, W.R., Pankey, S.C., Bouchard, L.S., Phan, D.H. and Puolakkainen, P.A., Stimulation of bone healing by transforming growth factor-beta 1 released from polymeric or ceramic implants. J. Appl. Biomater., 1994, 5, 141-150.
24. 24. Elgendy, H.M., Norman, M.E., Keaton, A.R. and Laurencin, C.T., Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material. Biomaterials, 1993, 14, 263-269.
25. 25. Meikle, M.C., Papaioannou, S., Ratledge, T.J. et al., Effect of poly DL-lactide-co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. Biomaterials, 1994, 15, 513-521.
26. 26. DeLustro, F., Smith, S.T., Sundsmo, J., Salem, G., Kincaid, S. and Ellingsworth, L.R., Reaction to injectable collagen: results in animal models and clinical use. Plast. Reconstruct. Surg., 1987, 79, 581-592.
27. 27. DeLustro, F., Dasch, J., Keefe, J. and Ellingsworth, L.R., Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives. Clin. Orthop. Rel. Res., 1990, 260, 263-279.
28. 28. Miyamoto, S., Takaoka, K., Okada, T. et al., Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein. Clin. Orthop. Rel. Res., 1992, 278, 274-285.
29. 29. Suganuma, J. and Alexander, H., Biological response of intramedullary bone to poly-L-lactic acid. J. Appl. Biomater., 1993, 4, 13-27.
30. 30. Daniels, A.U., Taylor, M.S., Andriano, K.P. and Heller, J., Toxicity of absorbable polymers proposed for fracture fixation devices. Proc. Orthop. Res. Soc., 1992, 17, 88.
31. 31. Takaoka, K., Nakahara, H., Yoshikawa, H., Musuhara, K., Tsuda, T. and Ono, K., Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein. Clin. Orthop. Rel. Res., 1988, 234, 250-254.
32. 32. Damien, C.J., Parsons, J.R., Benedict, J.J. and Weisman, D.S., Investigation of hydroxyapatite and calcium sulfate supplemented with an osteoinductive factor. J. Biomed. Mater. Res., 1990, 24, 639-654.
33. 33. Urist, M.R., Leitze, A. and Dawson, E., β-Tricalcium phosphate delivery system for bone morphogenetic proteins. Clin. Orthop. Rel. Res., 1984, 187, 277-280.
34. 34. van Blitterswijk, C.A., Hesseling, S.C., Grote, J.J., Koerten, H.K. and de Groot, K., The biocompatibility of hydroxyapatite ceramic: a study of retrieved human middle ear implants. J. Biomed. Mater. Res., 1990, 24, 433-453.
35. 35. van Blitterswijk, C.A., Grote, J.J., Juijpers, W., Daems, Wth. and de Groot, K., Macropore tissue ingrowth: a quantitative and qualitative study on hydroxyapatite ceramic. Biomaterials, 1986, 7, 136-143.
36. 36. Chesmel, K.D., Beight, J.L., Rothman, R.H. and Tuan, R.S., TGF-β enhances osseointegration in vivo. Bioceramics, 1993, 6, 21-26.
37. 37. Ellerby, L.M., Nishida, C.R., Nishida, F., et al., Encapsulation of proteins in transparent porous silicate glasses prepared by the sol-gel method. Science, 1992, 25, 1113-1115.
38. 38. Brinker, C.J. and Scherer, G., Sol-Gel Science: The Physics and Chemistry of Sol-Gel Precessing. Academic Press, Boston, MA, 1990.
39. 39. Lyons, R.M., Keski-Oja, J. and Moses, H., Proteolytic activation of latent transforming growth factor-β from fibroblast-conditioned medium. J. Cell Biol., 1988, 106, 1659-1665.
40. 40. Derynk, R., Jarret, J.A., Chen, E.Y. et al., Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature, 1985, 316, 701-705.
41. 41. Nicoll, S.B., Denker, A.E. and Tuan, R.S., In vitro characterization of TGF-β1 loaded composites of biodegradable polymer and mesenchymal cells. Cells Mater., 1995, 5, 231-244.
42. 42. Sporn, M.B., Roberts, A.B., Wakefield, L.M. and Assoian, R.K., Transforming growth factor-β: biological function and chemical structure. Science, 1986, 233, 532-534.
43. 43. Tan, B.H., Santos, E.M., Radin, S. and Ducheyne, P., Ultramicroscopic pore size and porosity of xerogels for controlled release of biological molecules. 5th World Biomaterials Congress, 1996, 161.
44. 44. Radin, S., Ducheyne, P. and Kamplain, T., A novel xerogel carrier for controlled release of biologically active molecules: I. Antibiotics (Vancomycin). 21st Annual Meeting of the Society for Biomaterials, San Francisco, 1995, p. 289.
45. 45. Falaize, S., Radin, S. and Ducheyne, P., In vitro behavior of silica-based xerogels intended for the controlled release of biomolecules. J. Biomater. Res., submitted.
46. 46. Hench, L.L., Bioactive ceramics. In Bioceramics: Material Characteristics Versus In Vivo Behavior, ed. P. Ducheyne and J.E. Lemons. Academic Press, New York, 1988, pp. 54-71.
47. 47. Ducheyne, P., El-Ghannam, A. and Shapiro, I., Effect of bioactive glass templates on osteoblast proliferation and in vitro synthesis of bone-like tissue. J. Cell Biochem., 1994, 56, 162-167.
48. 48. Schepers, E., deClercq, M., Ducheyne, P. and Kempereers, R., Bioactive glass particulate material as a filler for bone lesions. J. Oral Rehab., 1991, 18(5), 439-452.
49. 49. Andersson, O.H. and Karlsson, K.H., On the bioactivity of silicate glass. J. Non-Cryst. Solids, 1991, 129, 145-151.
50. 50. Li, P., Ohtsuki, C., Kokubo, T. et al., Apatite formation induced by silica gel in a simulated body fluid. J. Am. Ceram. Soc., 1992, 75, 2094-2097.
51. 51. Li, P., Ye, X., Kangashiemi, I., deBlieck-Hogervorst, J.M.A., Klein, C.P.A.T. and deGroot, K., In vivo calcium phosphate formation induced by sol-gel-prepared silica. J. Biomed. Mater. Res., 1995, 29, 325-328.
52. 52. Santos, E., Bioactive sol-gel derived materials as delivery vehicles for bone growth factors. Ph.D. Thesis, University of Pennsylvania, 1996.
53. 53. Denker, A.E., Nicoll, S.B. and Tuan, R.S., Formation of cartilage-like spheroids by micromass cultures of C3H10T1/2 cells upon treatment with transforming growth factor-β. Differentiation, 1995, 59, 25-34.